Letter: faecal microbiota transplantation for irritable bowel syndrome-which improvements are required? Authors' reply

被引：0
|
作者：
Perttu, Lahtinen [1 ,2 ]
Jonna, Jalanka [3 ]
Anna, Hartikainen [3 ]
Eero, Mattila [4 ]
Markku, Hillila [2 ,5 ]
Jari, Punkkinen [6 ]
Jari, Koskenpato [7 ]
Veli-Jukka, Anttila [2 ,4 ]
Jyrki, Tillonen [1 ]
Reetta, Satokari [3 ]
Perttu, Arkkila [2 ,8 ]
机构：
[1] Paijat Hame Cent Hosp, Dept Gastroenterol, Lahti, Finland
[2] Univ Helsinki, Fac Med, Helsinki, Finland
[3] Univ Helsinki, Fac Med, Human Microbiome Res Program, Helsinki, Finland
[4] Helsinki Univ Hosp, Dept Infect Dis, Helsinki, Finland
[5] Helsinki Univ Hosp, Dept Gastroenterol, Espoo, Finland
[6] Porvoo Hosp, Dept Gastroenterol, Porvoo, Finland
[7] Aava Med Ctr, Dept Gastroenterol, Helsinki, Finland
[8] Helsinki Univ Hosp, Dept Gastroenterol, Helsinki, Finland
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2020年 / 52卷 / 11-12期
关键词：
SYNDROME-ROOM;
D O I：
10.1111/apt.16122
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1754 / 1755
页数：2
相关论文
共 50 条
  • [21] Letter: Antibiotics prescription and new-onset irritable bowel syndrome-Authors' reply
    Staller, Kyle
    Ludvigsson, Jonas F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 300 - 301
  • [22] Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
    Durban, Ana
    Abellan, Juan J.
    Jimenez-Hernandez, Nuria
    Artacho, Alejandro
    Garrigues, Vicente
    Ortiz, Vicente
    Ponce, Julio
    Latorre, Amparo
    Moya, Andres
    FEMS MICROBIOLOGY ECOLOGY, 2013, 86 (03) : 581 - 589
  • [23] Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome
    Luo, Yuying
    Jodorkovsky, Daniela
    Singh, Priyanka
    Keefer, Laurie A. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (01) : 137 - 138
  • [24] Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome
    Ianiro, Gianluca
    Eusebi, Leonardo H.
    Black, Christopher J.
    Gasbarrini, Antonio
    Cammarota, Giovanni
    Ford, Alexander C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (03) : 240 - 248
  • [25] Factors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome
    El-Salhy, Magdy
    Gilja, Odd Helge
    Hatlebakk, Jan Gunnar
    MICROBES AND INFECTION, 2024, 26 (08)
  • [26] Fecal microbiota transplantation for managing irritable bowel syndrome
    El-Salhy, Magdy
    Mazzawi, Tarek
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (05) : 439 - 445
  • [27] Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome
    Holster, S.
    Repsilber, D.
    Geng, D.
    Hyotylainen, T.
    Salonen, A.
    Lindqvist, C. M.
    Rajan, S. K.
    de Vos, W. M.
    Brummer, R. J.
    Konig, J.
    BENEFICIAL MICROBES, 2021, 12 (01) : 17 - 30
  • [28] Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
    Amin Talebi Bezmin Abadi
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2017, (04) : 208 - 209
  • [29] Generalized anxiety disorder and irritable bowel syndrome: authors' reply
    Lee, S.
    Wu, J.
    Ma, Y. L.
    Tsang, A.
    Guo, W. -J.
    Sung, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (10) : 1088 - 1089
  • [30] Dried plums, constipation and the irritable bowel syndrome: authors' reply
    Attaluri, A.
    Valestin, J.
    Donahoe, R.
    Brown, K.
    Rao, S. S. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) : 397 - 398
12345